Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference

RNA interference (RNAi) is a potent mechanism that silences mRNA and protein expression in all cells and tissue types. RNAi is known to exert many of its functional effects in the cytoplasm, and thus, the cellular localization of target mRNA may impact observed potency. Here, we demonstrate that cel...

Full description

Bibliographic Details
Main Authors: Chantal M. Ferguson, Dimas Echeverria, Matthew Hassler, Socheata Ly, Anastasia Khvorova
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Molecular Therapy: Nucleic Acids
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253120301670
_version_ 1819082421725822976
author Chantal M. Ferguson
Dimas Echeverria
Matthew Hassler
Socheata Ly
Anastasia Khvorova
author_facet Chantal M. Ferguson
Dimas Echeverria
Matthew Hassler
Socheata Ly
Anastasia Khvorova
author_sort Chantal M. Ferguson
collection DOAJ
description RNA interference (RNAi) is a potent mechanism that silences mRNA and protein expression in all cells and tissue types. RNAi is known to exert many of its functional effects in the cytoplasm, and thus, the cellular localization of target mRNA may impact observed potency. Here, we demonstrate that cell identity has a profound impact on accessibility of apolipoprotein E (ApoE) mRNA to RNAi. We show that, whereas both neuronal and glial cell lines express detectable ApoE mRNA, in neuronal cells, ApoE mRNA is not targetable by RNAi. Screening of a panel of thirty-five chemically modified small interfering RNAs (siRNAs) did not produce a single hit in a neuronal cell line, whereas up to fifteen compounds showed strong efficacy in glial cells. Further investigation of the cellular localization of ApoE mRNA demonstrates that ApoE mRNA is partially spliced and preferentially localized to the nucleus (∼80%) in neuronal cells, whereas more than 90% of ApoE mRNA is cytoplasmic in glial cells. Such an inconsistency in intracellular localization and splicing might provide an explanation for functional differences in RNAi compounds. Thus, cellular origin might have an impact on accessibility of mRNA to RNAi and should be taken into account during the screening process.
first_indexed 2024-12-21T20:16:25Z
format Article
id doaj.art-6a92b1c08c20454aad65ef9c7254dc4f
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-21T20:16:25Z
publishDate 2020-09-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-6a92b1c08c20454aad65ef9c7254dc4f2022-12-21T18:51:36ZengElsevierMolecular Therapy: Nucleic Acids2162-25312020-09-0121384393Cell Type Impacts Accessibility of mRNA to Silencing by RNA InterferenceChantal M. Ferguson0Dimas Echeverria1Matthew Hassler2Socheata Ly3Anastasia Khvorova4RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA; Corresponding author: Anastasia Khvorova, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA.RNA interference (RNAi) is a potent mechanism that silences mRNA and protein expression in all cells and tissue types. RNAi is known to exert many of its functional effects in the cytoplasm, and thus, the cellular localization of target mRNA may impact observed potency. Here, we demonstrate that cell identity has a profound impact on accessibility of apolipoprotein E (ApoE) mRNA to RNAi. We show that, whereas both neuronal and glial cell lines express detectable ApoE mRNA, in neuronal cells, ApoE mRNA is not targetable by RNAi. Screening of a panel of thirty-five chemically modified small interfering RNAs (siRNAs) did not produce a single hit in a neuronal cell line, whereas up to fifteen compounds showed strong efficacy in glial cells. Further investigation of the cellular localization of ApoE mRNA demonstrates that ApoE mRNA is partially spliced and preferentially localized to the nucleus (∼80%) in neuronal cells, whereas more than 90% of ApoE mRNA is cytoplasmic in glial cells. Such an inconsistency in intracellular localization and splicing might provide an explanation for functional differences in RNAi compounds. Thus, cellular origin might have an impact on accessibility of mRNA to RNAi and should be taken into account during the screening process.http://www.sciencedirect.com/science/article/pii/S2162253120301670
spellingShingle Chantal M. Ferguson
Dimas Echeverria
Matthew Hassler
Socheata Ly
Anastasia Khvorova
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
Molecular Therapy: Nucleic Acids
title Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
title_full Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
title_fullStr Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
title_full_unstemmed Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
title_short Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
title_sort cell type impacts accessibility of mrna to silencing by rna interference
url http://www.sciencedirect.com/science/article/pii/S2162253120301670
work_keys_str_mv AT chantalmferguson celltypeimpactsaccessibilityofmrnatosilencingbyrnainterference
AT dimasecheverria celltypeimpactsaccessibilityofmrnatosilencingbyrnainterference
AT matthewhassler celltypeimpactsaccessibilityofmrnatosilencingbyrnainterference
AT socheataly celltypeimpactsaccessibilityofmrnatosilencingbyrnainterference
AT anastasiakhvorova celltypeimpactsaccessibilityofmrnatosilencingbyrnainterference